SEARCH

SEARCH BY CITATION

References

  • 1
    Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., Witzenbichler B., Schatteman G., Isner J.M., Isolation of putative progenitor endothelial cells for angiogenesis, Science, 275: 964967, 1997.
  • 2
    Shi Q., Rafii S., Wu M.H., Wijelath E.S., Yu C., Ishida A., Fujita Y., Kothari S., Mohle R., Sauvage L.R., Moore M.A., Storb R.F., Hammond W.P., Evidence for circulating bone marrow-derived endothelial cells, Blood, 92: 362367, 1998.
  • 3
    Asahara T., Masuda H., Takahashi T., Kalka C., Pastore C., Silver M., Kearne M., Magner M., Isner J.M., Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization, Circ Res, 85: 221228, 1999.
  • 4
    Gehling U.M., Ergun S., Schumacher U., Wagener C., Pantel K., Otte M., Schuch G., Schafhausen P., Mende T., Kilic N., Kluge K., Schafer B., Hossfeld D.K., Fiedler W., In vitro differentiation of endothelial cells from CD 133-positive progenitor cells, Blood, 95: 31063112, 2000.
  • 5
    Gunsilius E., Petzer A.L., Duba H.C., Kahler C.M., Gastl G., Circulating endothelial cells after transplantation, Lancet, 357: 14491450, 2001.
  • 6
    Lin Y., Weisdorf D.J., Solovey A., Hebbel R.P., Origins of circulating endothelial cells and endothelial outgrowth from blood, J. Clin. Invest., 105: 7177, 2000.
  • 7
    Peichev M., Naiyer A.J., Pereira D., Zhu Z., Lane W.J., Williams M., Oz M.C., Hicklin D.J., Witte L., Moore M.A., Rafii S., Expression of VEGFR-2 and CD133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors, Blood, 95: 952958, 2000.
  • 8
    Nieda M., Nicol A., Denning Kendall P., Sweetenham J., Bradley B., Hows J., Endothelial cell precursors are normal components of human umbilical cord blood, Br J Haematol, 98: 775777, 1997.
  • 9
    Murohara T., Ikeda H., Duan J., Shintani S., Sasaki K., Eguchi H., Onitsuka I., Matsui K., Imaizumi T., Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization, J. Clin. Invest., 105: 15271536, 2000.
  • 10
    Hatzopoulos A.K., Folkman J., Vasile E., Eiselen G.K., Rosenberg R.D., Isolation and characterization of endothelial progenitor cells from mouse embryos, Development, 125: 14571468, 1998.
  • 11
    Springer M.L., Chen A.S., Kraft P.E., Bednarski M., Blau H.M., VEGF gene delivery to muscle: potential role for vasculogenesis in adults, Mol. Cell, 2: 54958, 1998.
  • 12
    Gill M., Dias S., Hattori K., Rivera M.L., Hicklin D., Witte L., Girardi L., Yurt R., Himel H., Rafii S., Vascular trauma induces rapid but transient mobilization of VEGFR2(+)CD133(+) endothelial precursor cells, Circ. Res., 88: 167174, 2001.
  • 13
    Asahara T., Takahashi T., Masuda H., Kalka C., Chen D., Iwaguro H., Inai Y., Silver M., Isner J.M., VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells, EMBO J., 18: 39643972, 1999.
  • 14
    Iwaguro H., Yamaguchi J., Kalka C., Murasawa S., Masuda H., Hayashi S., Silver M., Li T., Isner JM., Asahara T., Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration, Circulation, 105: 732738, 2002.
  • 15
    Kalka C., Masuda H., Takahashi T., Kalka Moll WM., Silver M., Kearney M., Li T., Isner JM., Asahara T., Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization, Proc. Natl. Acad. Sci. USA, 97: 34223427, 2000.
  • 16
    Schatteman GC., Hanlon HD., Jiao C., Dodds SG., Christy BA., Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice, J. Clin. Invest., 106: 571578, 2000.
  • 17
    Takahashi T., Kalka C., Masuda H., Chen D., Silver M., Kearney M., Magner M., Isner J.M., Asahara T., Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization, Nat. Med., 5: 434438, 1999.
  • 18
    Edelberg JM., Tang L., Hattori K., Lyden D., Rafii S., Young adult bone marrow-derived endothelial precursor cells restore aging-impaired cardiac angiogenic function, Circ. Res., 90: E89E93, 2002.
  • 19
    Shintani S., Murohara T., Ikeda H., Ueno T., Honma T., Katoh A., Sasaki Ki., Shimada T., Oike Y., Imaizumi T., Mobilization of endothelial progenitor cells in patients with acute myocardial infarction., Circulation, 103: 27762779, 2001.
  • 20
    Bhattacharya V., McSweeney PA., Shi Q., Bruno B., Ishida A., Nash R., Storb RF., Sauvage LR., Hammond WP., Wu MH., Enhanced endothelialization and microvessel formation in polyester grafts seeded with CD34(+) bone marrow cells, Blood, 95: 581585, 2000.
  • 21
    Kaushal S., Amiel GE., Guleserian K.J., Shapira O.M., Perry T., Sutherland F.W., Rabkin E., Moran A.M., Schoen F.J., Atala A., Soker S., Bischoff J., Mayer J.E. Jr., Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo, Nat. Med., 7: 10351040, 2001.
  • 22
    Crosby J.R., Kaminski W.E., Schatteman G., Martin P.J., Raines E.W., Seifert R.A., Bowen Pope D.F., Endothelial cells of hematopoietic origin make a significant contribution to adult blood vessel formation, Circ. Res., 87: 728730, 2000.
  • 23
    Murayama T., Tepper O.M., Silver M., Ma H., Losordo D.W., Isner J.M., Asahara T., Kalka C., Determination of bone marrow-derived endothelial progenitor cell significance in angiogenic growth factor-induced neovascularization in vivo, Exp. Hematol., 30: 967972, 2002.
  • 24
    Reyes M., Dudek A., Jahagirdar B., Koodie L., Marker P.H., Verfaillie C.M., Origin of endothelial progenitors in human postnatal bone marrow, J. Clin. Invest., 109: 337346, 2002.
  • 25
    Tamaki T., Akatsuka A., Ando K., Nakamura Y., Matsuzawa H., Hotta T., Roy R.R., Edgerton V.R., Identification of myogenic-endothelial progenitor cells in the interstitial spaces of skeletal muscle, J. Cell. Biol., 157: 571577, 2002.
  • 26
    Vasa M., Fichtlscherer S., Aicher A., Adler K., Urbich C., Martin H., Zeiher A.M., Dimmeler S., Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease, Circ. Res., 89: E1E7, 2001.
  • 27
    Tepper O.M., Galiano R.D., Capla J.M., Kalka C., Gagne P.J., Jacobowitz G.R., Levine J.P., Gurtner G.C., Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures, Circulation, 106: 27816, 2002.
  • 28
    Valgimigli M., Rigolin G.M., Fucili A., Della Porta M., Soukhomovskaia O., Malagutti P., Bugli A.M., Bragotti L.Z., Francolini G., Mauro E., Castoldi G., Ferrari R., CD34+ and Endothelial Progenitor Cells in Patients With Various Degrees of Congestive Heart Failure, Circulation, 110: 12091212, 2004.
  • 29
    Kalka C., Masuda H., Takahashi T., Gordon R., Tepper O., Gravereaux E., Pieczek A., Iwaguro H., Hayashi SI., Isner JM., Asahara T., Vascular endothelial growth factor (165) gene transfer augments circulating endothelial progenitor cells in human subjects, Circ. Res., 86: 11981202, 2000.
  • 30
    Hattori K., Dias S., Heissig B., Hackett NR., Lyden D., Tateno M., Hicklin DJ., Zhu Z., Witte L., Crystal R.G., Moore M.A., Rafii S., Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells, J. Exp. Med., 193: 10051014, 2001.
  • 31
    Yamaguchi J., Kusano K.F., Masuo O., Kawamoto A., Silver M., Murasawa S., Bosch Marce M., Masuda H., Losordo D.W., Isner J.M., Asahara T., Stromal cell-derived factor–1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization, Circulation, 107: 13221328, 2003.
  • 32
    Heeschen C., Aicher A., Lehmann R., Fichtlscherer S., Vasa M., Urbich C., Mildner Rihm C., Martin H., Zeiher A.M., Dimmeler S., Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization, Blood, 102: 13401346. 2003.
  • 33
    Iwakura A., Luedemann C., Shastry S., Hanley A., Kearney M., Aikawa R., Isner J.M., Asahara T., Losordo D.W., Estrogen-mediated, endothelial nitric oxide synthase-dependent mobilization of bone marrow-derived endothelial progenitor cells contributes to reendothelialization after arterial injury, Circulation, 108: 31153121, 2003.
  • 34
    Strehlow K., Werner N., Berweiler J., Link A., Dirnagl U., Priller J., Laufs K., Ghaeni L., Milosevic M., Bohm M., Nickenig G., Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation, Circulation, 107: 30593065, 2003.
  • 35
    Kureishi Y., Luo Z., Shiojima I., Bialik A., Fulton D., Lefer D.J., Sessa W.C., Walsh K., The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals, Nat. Med., 6: 10041010, 2000.
  • 36
    Llevadot J., Murasawa S., Kureishi Y., Uchida S., Masuda H., Kawamoto A., Walsh K., Isner J.M., Asahara T., HMG-CoA reductase inhibitor mobilizes bone marrow—derived endothelial progenitor cells, J. Clin. Invest., 108: 399405, 2001.
  • 37
    Dimmeler S., Aicher A., Vasa M., Mildner Rihm C., Adler K., Tiemann M., Rutten H., Fichtlscherer S., Martin H., Zeiher AM., HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway, J. Clin. Invest., 108: 391397, 2001.
  • 38
    Lyden D., Hattori K., Dias S., Costa C., Blaikie P., Butros L., Chadburn A., Heissig B., Marks W., Witte L., Wu Y., Hicklin D., Zhu Z., Hackett N.R., Crystal RG., Moore M.A., Hajjar K.A., Manova K., Benezra R., Rafii S., Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth, Nat. Med., 7: 11941201, 2001.
  • 39
    Kocher A.A., Schuster M.D., Szabolcs M.J., Takuma S., Burkhoff D., Wang J., Homma S., Edwards N.M., Itescu S., Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function, Nat. Med., 7: 430436, 2001.
  • 40
    Taguchi A., Soma T., Tanaka H., Kanda T., Nishimura H., Yoshikawa H., Tsukamoto Y., Iso H., Fujimori Y., Stern D.M., Naritomi H., Matsuyama T., Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model, J. Clin. Invest., 114: 330338, 2004.
  • 41
    Nagaya N., Kangawa K., Kanda M., Uematsu M., Horio T., Fukuyama N., Hino J., Harada Shiba M., Okumura H., Tabata Y., Mochizuki N., Chiba Y., Nishioka K., Miyatake K., Asahara T., Hara H., Mori H., Hybrid cell-gene therapy for pulmonary hypertension based on phagocytosing action of endothelial progenitor cells, Circulation, 108: 889895, 2003.